82 results
6-K
EX-99
BLRX
Bioline Rx Ltd
10 Apr 24
BioLineRx Accesses Second Tranche of $20 Million Under Previously Announced $40 Million
7:24am
for multiple myeloma in China
Completion of recruitment in the Phase 1 pilot study of motixafortide for hematopoietic stem cell mobilization for gene … recruitment in the Chemo4MetPanc Phase 2b randomized clinical trial in first-line metastatic pancreatic cancer sponsored by Columbia University
Preparation
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
institutional review board and other regulatory approvals to commence a clinical trial;
slower-than-anticipated patient recruitment and enrollment;
negative
6-K
EX-99
BLRX
Bioline Rx Ltd
11 May 22
BioLineRx Reports First Quarter 2022 Financial Results
7:14am
).
Completed recruitment of part 2 of ongoing Phase 1/2a trial of AGI-134 in solid tumors;
Ended the first quarter on solid financial footing, with cash
6-K
EX-99
hhn4dunc62gyvmyossq
16 Mar 22
BioLineRx Reports Fourth Quarter 2021 Financial Results
7:11am
6-K
EX-99
m9tx4spksze3vormvcx
24 Jan 22
BioLineRx Announces Completion of Enrollment of Phase 1/2a
7:11am
6-K
EX-99
6bdwdaurq3kopcvjn
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-99
olbggte60ybdac42j3
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-99
k3cnk3 a58e
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-99
zed3i4c 07v
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am
6-K
EX-99
9i9dblsz 5v8
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
424B5
9wx47 vydjvc0ci
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
gie5xo1
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
cou 26wu2
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
m1hwvjc7qo ft7dgb
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
90q6d
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
6-K
EX-99
eqgxqa 81f
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am